1. Home
  2. ESQ vs RGNX Comparison

ESQ vs RGNX Comparison

Compare ESQ & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$104.32

Market Cap

858.2M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$14.16

Market Cap

732.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
RGNX
Founded
2006
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.2M
732.0M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
ESQ
RGNX
Price
$104.32
$14.16
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$113.00
$30.78
AVG Volume (30 Days)
61.1K
641.1K
Earning Date
01-22-2026
11-06-2025
Dividend Yield
0.67%
N/A
EPS Growth
14.70
N/A
EPS
5.68
N/A
Revenue
$131,743,000.00
$161,318,000.00
Revenue This Year
N/A
$132.80
Revenue Next Year
$18.55
$45.32
P/E Ratio
$18.50
N/A
Revenue Growth
13.37
91.30
52 Week Low
$68.90
$5.04
52 Week High
$110.71
$15.41

Technical Indicators

Market Signals
Indicator
ESQ
RGNX
Relative Strength Index (RSI) 50.07 57.24
Support Level $105.38 $12.91
Resistance Level $107.88 $15.41
Average True Range (ATR) 2.64 0.91
MACD -0.41 0.03
Stochastic Oscillator 14.53 55.89

Price Performance

Historical Comparison
ESQ
RGNX

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: